\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\ \(157\)\
\-\ type\\ ii\\ endoleaks\\ are\\ a\\ result\\ of\\ flow\\ from\\ small\\ arteries\\ such\\ as\\ the\\ lumbars\\ or\\ the\\ inferior\\ mesenteric\\ artery\\ \\(ima\\)\\.\\ detection\\ of\\ a\\ type\\ ii\\ endoleak\\ can\\ be\\ accomplished\\ by\\ routine\\ duplex\\ ultrasound\\,\\ but\\ is\\ more\\ commonly\\ performed\\ by\\ ct\\ scanning\\.\\ both\\ methods\\ have\\ some\\ disadvantages\\;\\ however\\,\\ the\\ most\\ serious\\ problem\\ is\\ related\\ to\\ ct\\ scanning\\.\\ the\\ timing\\ of\\ contrast\\ injection\\ during\\ the\\ ct\\ scan\\ will\\ determine\\ whether\\ a\\ type\\ ii\\ endoleak\\ is\\ visible\\.\\ due\\ to\\ the\\ nature\\ of\\ retrograde\\ flow\\,\\ these\\ can\\ be\\ very\\ low\\-flow\\ systems\\.\\ delayed\\ films\\ may\\ be\\ necessary\\ to\\ assess\\ late\\ perfusion\\ within\\ the\\ sac\\ and\\ should\\ be\\ performed\\ with\\ any\\ suspicion\\ of\\ type\\ ii\\ endoleak\\.\ \(0\)\
\-\ axial\\ computed\\ tomography\\ images\\ demonstrate\\ 2\\ collateral\\ vessels\\ in\\ the\\ aneurysm\\ sac\\ on\\ each\\ side\\.\\ this\\ is\\ consistent\\ with\\ retrograde\\ filling\\ by\\ these\\ vessels\\ and\\ constitutes\\ the\\ presence\\ of\\ a\\ type\\ 2\\ endograft\\ leak\\.\ \(0\)\
\-\ endograft\\ leak\\ \\-\\ type\\ ii\\ involving\\ the\\ l3\\ lumbar\\ artery\\ and\\ inferior\\ mesenteric\\ artery\\.\ \(0\)\
\-\ none\\.\\ this\\ finding\\ is\\ very\\ specific\\ for\\ a\\ type\\ ii\\ endograft\\ leak\\.\ \(0\)\
\-\ 59\\ year\\ old\\ black\\ male\\ with\\ long\\-standing\\ history\\ of\\ hypertension\\,\\ hyperlipidemia\\,\\ and\\ type\\ ii\\ diabetes\\ who\\ was\\ found\\ to\\ have\\ an\\ infrarenal\\ abdominal\\ aortic\\ aneurysm\\.\\ the\\ patient\\ underwent\\ an\\ endograft\\ repair\\ 10\\ days\\ prior\\ to\\ ct\\ scan\\.\\ the\\ ct\\ scan\\ was\\ ordered\\ for\\ routine\\ post\\-operative\\ evaluation\\.\ \(0\)\
\-\ interventionalists\\ debate\\ the\\ significance\\ of\\ type\\ ii\\ endoleaks\\,\\ as\\ many\\ of\\ these\\ leaks\\ will\\ spontaneously\\ resolve\\,\\ regardless\\ of\\ graft\\ type\\.\\ \ \(0\)\
\-\ some\\ patients\\ will\\ demonstrate\\ stability\\ or\\ even\\ shrinkage\\ of\\ the\\ aneurysm\\ sac\\ in\\ the\\ presence\\ of\\ a\\ patent\\ type\\ ii\\ endoleak\\;\\ usually\\ they\\ can\\ be\\ safely\\ observed\\ for\\ 6\\ months\\.\\ \ \(0\)\
\-\ an\\ aggressive\\ approach\\ to\\ treating\\ all\\ persistent\\ endoleaks\\ at\\ 6\\ months\\ is\\ usually\\ adopted\\ and\\ consideration\\ of\\ further\\ conservative\\ treatment\\ only\\ when\\ a\\ type\\ ii\\ endoleak\\ is\\ difficult\\ to\\ treat\\ and\\ the\\ aneurysm\\ sac\\ is\\ shrinking\\ in\\ size\\.\\ \ \(0\)\
\-\ it\\ should\\ be\\ noted\\ that\\ most\\ type\\ ii\\ endoleaks\\ have\\ a\\ benign\\ course\\ and\\ aggressive\\ treatment\\ should\\ not\\ involve\\ excessive\\ patient\\ morbidity\\.\\ \ \(0\)\
\-\ in\\ this\\ setting\\,\\ successful\\ embolization\\ performed\\ via\\ transarterial\\ or\\ translumbar\\ techniques\\ can\\ be\\ peroformed\\ by\\ a\\ skilled\\ interventionalist\\ as\\ clinically\\ required\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ type\\:\\ 0\\.3797217974386882\ \(0\)\
\-\ ii\\:\\ 0\\.37762916200865476\ \(0\)\
\-\ endoleak\\:\\ 0\\.30623375208388043\ \(0\)\
\-\ endoleaks\\:\\ 0\\.26615026314947593\ \(0\)\
\-\ endograft\\:\\ 0\\.23260728730696054\ \(0\)\
\-\ sac\\:\\ 0\\.15508700094193734\ \(0\)\
\-\ leak\\:\\ 0\\.13973247375964112\ \(0\)\
\-\ the\\:\\ 0\\.13901002454578812\ \(0\)\
\-\ aneurysm\\:\\ 0\\.13261314631143348\ \(0\)\
\-\ be\\:\\ 0\\.1236415995239348\ \(0\)\
\-\ of\\:\\ 0\\.11077167428186449\ \(0\)\
\-\ is\\:\\ 0\\.09539329966822176\ \(0\)\
\-\ scanning\\:\\ 0\\.0947221076174826\ \(0\)\
\-\ retrograde\\:\\ 0\\.09315498250642743\ \(0\)\
\-\ can\\:\\ 0\\.09139700507321534\ \(0\)\
\-\ flow\\:\\ 0\\.08700534908633788\ \(0\)\
\-\ should\\:\\ 0\\.0852326700355354\ \(0\)\
\-\ will\\:\\ 0\\.08407361233819324\ \(0\)\
\-\ ct\\:\\ 0\\.08288347597946184\ \(0\)\
\-\ artery\\:\\ 0\\.08112669582308105\ \(0\)\
\-\ scan\\:\\ 0\\.07749824021752687\ \(0\)\
\-\ performed\\:\\ 0\\.0772780548740279\ \(0\)\
\-\ to\\:\\ 0\\.07619719795377762\ \(0\)\
\-\ aggressive\\:\\ 0\\.07530544212956389\ \(0\)\
\-\ mesenteric\\:\\ 0\\.07519022598874815\ \(0\)\
\-\ by\\:\\ 0\\.07396115139111975\ \(0\)\
\-\ these\\:\\ 0\\.07376380065509675\ \(0\)\
\-\ lumbars\\:\\ 0\\.06963249437740492\ \(0\)\
\-\ interventionalists\\:\\ 0\\.06963249437740492\ \(0\)\
\-\ transarterial\\:\\ 0\\.06963249437740492\ \(0\)\
\-\ translumbar\\:\\ 0\\.06963249437740492\ \(0\)\
\-\ peroformed\\:\\ 0\\.06963249437740492\ \(0\)\
\-\ interventionalist\\:\\ 0\\.06963249437740492\ \(0\)\
\-\ vessels\\:\\ 0\\.06757669373994646\ \(0\)\
\-\ routine\\:\\ 0\\.06743791036417984\ \(0\)\
\-\ have\\:\\ 0\\.06525424971130238\ \(0\)\
\-\ disadvantages\\:\\ 0\\.06434167900681202\ \(0\)\
\-\ constitutes\\:\\ 0\\.06434167900681202\ \(0\)\
\-\ shrinkage\\:\\ 0\\.06434167900681202\ \(0\)\
\-\ skilled\\:\\ 0\\.06434167900681202\ \(0\)\
\-\ and\\:\\ 0\\.0629813671704559\ \(0\)\
\-\ adopted\\:\\ 0\\.06263841689415629\ \(0\)\
\-\ shrinking\\:\\ 0\\.06263841689415629\ \(0\)\
\-\ presence\\:\\ 0\\.062570096168669\ \(0\)\
\-\ very\\:\\ 0\\.06246999045786533\ \(0\)\
\-\ inferior\\:\\ 0\\.05924413184637287\ \(0\)\
\-\ ima\\:\\ 0\\.058151821826740134\ \(0\)\
\-\ safely\\:\\ 0\\.058151821826740134\ \(0\)\
\-\ debate\\:\\ 0\\.0573476015235634\ \(0\)\
\-\ leaks\\:\\ 0\\.0573476015235634\ \(0\)\
\-\ usually\\:\\ 0\\.05482209848111004\ \(0\)\
\-\ some\\:\\ 0\\.054791898538135986\ \(0\)\
\-\ timing\\:\\ 0\\.05477929780507295\ \(0\)\
\-\ infrarenal\\:\\ 0\\.053297298520783236\ \(0\)\
\-\ regardless\\:\\ 0\\.05286100645614725\ \(0\)\
\-\ as\\:\\ 0\\.0524766157802453\ \(0\)\
\-\ methods\\:\\ 0\\.05205678615297051\ \(0\)\
\-\ months\\:\\ 0\\.05068946556608192\ \(0\)\
\-\ duplex\\:\\ 0\\.05066511967559031\ \(0\)\
\-\ an\\:\\ 0\\.049950482854892495\ \(0\)\
\-\ serious\\:\\ 0\\.04922062922892871\ \(0\)\
\-\ significance\\:\\ 0\\.048961857562934565\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.047785220321824314\ \(0\)\
\-\ treating\\:\\ 0\\.047785220321824314\ \(0\)\
\-\ excessive\\:\\ 0\\.04695922244867566\ \(0\)\
\-\ morbidity\\:\\ 0\\.046765970782377625\ \(0\)\
\-\ accomplished\\:\\ 0\\.04657749125321371\ \(0\)\
\-\ techniques\\:\\ 0\\.04639355384444411\ \(0\)\
\-\ resolve\\:\\ 0\\.046038465025410785\ \(0\)\
\-\ or\\:\\ 0\\.045442039970369615\ \(0\)\
\-\ detection\\:\\ 0\\.04537430430499741\ \(0\)\
\-\ graft\\:\\ 0\\.04537430430499741\ \(0\)\
\-\ most\\:\\ 0\\.0453207322948691\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04527214000070239\ \(0\)\
\-\ this\\:\\ 0\\.04488503166977208\ \(0\)\
\-\ black\\:\\ 0\\.044617940165461424\ \(0\)\
\-\ spontaneously\\:\\ 0\\.04433520291275504\ \(0\)\
\-\ treat\\:\\ 0\\.04406256560607722\ \(0\)\
\-\ stability\\:\\ 0\\.043929813858335824\ \(0\)\
\-\ consideration\\:\\ 0\\.043929813858335824\ \(0\)\
\-\ perfusion\\:\\ 0\\.04367104219234167\ \(0\)\
\-\ in\\:\\ 0\\.04332694600186225\ \(0\)\
\-\ l3\\:\\ 0\\.043178417524440474\ \(0\)\
\-\ problem\\:\\ 0\\.04294353643537483\ \(0\)\
\-\ whether\\:\\ 0\\.042604234660433296\ \(0\)\
\-\ successful\\:\\ 0\\.04227937571496147\ \(0\)\
\-\ tomography\\:\\ 0\\.042174090830602064\ \(0\)\
\-\ systems\\:\\ 0\\.042070238438148416\ \(0\)\
\-\ computed\\:\\ 0\\.04196778007968593\ \(0\)\
\-\ approach\\:\\ 0\\.04176689919426459\ \(0\)\
\-\ collateral\\:\\ 0\\.04166840707808278\ \(0\)\
\-\ treatment\\:\\ 0\\.041482347121521795\ \(0\)\
\-\ suspicion\\:\\ 0\\.041380333905482465\ \(0\)\
\-\ each\\:\\ 0\\.04128667588262082\ \(0\)\
\-\ 59\\:\\ 0\\.04128667588262082\ \(0\)\
\-\ late\\:\\ 0\\.04110273847385122\ \(0\)\
\-\ determine\\:\\ 0\\.04049176983697252\ \(0\)\
\-\ setting\\:\\ 0\\.04049176983697252\ \(0\)\
\-\ assess\\:\\ 0\\.040244190303624965\ \(0\)\
\-\ diabetes\\:\\ 0\\.03977189329912899\ \(0\)\
\-\ for\\:\\ 0\\.039591372638614564\ \(0\)\
\-\ patent\\:\\ 0\\.039472520297525834\ \(0\)\
\-\ observed\\:\\ 0\\.038771750235484334\ \(0\)\
\-\ nature\\:\\ 0\\.038444101948451256\ \(0\)\
\-\ visible\\:\\ 0\\.038380226821748784\ \(0\)\
\-\ involve\\:\\ 0\\.03831688178519531\ \(0\)\
\-\ ordered\\:\\ 0\\.038254058112878055\ \(0\)\
\-\ embolization\\:\\ 0\\.03794746938699648\ \(0\)\
\-\ injection\\:\\ 0\\.037887602153847594\ \(0\)\
\-\ even\\:\\ 0\\.03662624669460427\ \(0\)\
\-\ necessary\\:\\ 0\\.036426678906226834\ \(0\)\
\-\ clinically\\:\\ 0\\.036184340041191844\ \(0\)\
\-\ difficult\\:\\ 0\\.03613678204873015\ \(0\)\
\-\ via\\:\\ 0\\.035588064446573656\ \(0\)\
\-\ lumbar\\:\\ 0\\.03515912952284211\ \(0\)\
\-\ arteries\\:\\ 0\\.034557792474746\ \(0\)\
\-\ films\\:\\ 0\\.0344810779285361\ \(0\)\
\-\ many\\:\\ 0\\.03432992381896861\ \(0\)\
\-\ delayed\\:\\ 0\\.034072399482513546\ \(0\)\
\-\ filling\\:\\ 0\\.03371895518208992\ \(0\)\
\-\ repair\\:\\ 0\\.03368449447751958\ \(0\)\
\-\ aortic\\:\\ 0\\.03365018865304292\ \(0\)\
\-\ conservative\\:\\ 0\\.03361603632270139\ \(0\)\
\-\ persistent\\:\\ 0\\.033548186692864385\ \(0\)\
\-\ hypertension\\:\\ 0\\.03331535281665731\ \(0\)\
\-\ related\\:\\ 0\\.033089411451155896\ \(0\)\
\-\ unknown\\:\\ 0\\.03299458994485363\ \(0\)\
\-\ specific\\:\\ 0\\.03299458994485363\ \(0\)\
\-\ result\\:\\ 0\\.0325967867832547\ \(0\)\
\-\ commonly\\:\\ 0\\.03221869261702123\ \(0\)\
\-\ course\\:\\ 0\\.032162151372580154\ \(0\)\
\-\ they\\:\\ 0\\.031111280477034507\ \(0\)\
\-\ required\\:\\ 0\\.031086776336897\ \(0\)\
\-\ involving\\:\\ 0\\.03049842411092709\ \(0\)\
\-\ was\\:\\ 0\\.03034935603192078\ \(0\)\
\-\ side\\:\\ 0\\.030079769034392786\ \(0\)\
\-\ underwent\\:\\ 0\\.02999448286111995\ \(0\)\
\-\ benign\\:\\ 0\\.02991013909578675\ \(0\)\
\-\ size\\:\\ 0\\.029482006340423063\ \(0\)\
\-\ finding\\:\\ 0\\.028620505923748325\ \(0\)\
\-\ further\\:\\ 0\\.028359373282450043\ \(0\)\
\-\ patient\\:\\ 0\\.028323792041164496\ \(0\)\
\-\ found\\:\\ 0\\.028173398714123818\ \(0\)\
\-\ any\\:\\ 0\\.028140066638896725\ \(0\)\
\-\ such\\:\\ 0\\.02800817509661039\ \(0\)\
\-\ during\\:\\ 0\\.027579150857419858\ \(0\)\
\-\ days\\:\\ 0\\.027563714991497363\ \(0\)\
\-\ only\\:\\ 0\\.02720232048594482\ \(0\)\
\-\ ultrasound\\:\\ 0\\.02685726589091129\ \(0\)\
\-\ evaluation\\:\\ 0\\.02655410920961575\ \(0\)\
\-\ when\\:\\ 0\\.0263016447188234\ \(0\)\
\-\ all\\:\\ 0\\.025919275976224097\ \(0\)\
\-\ however\\:\\ 0\\.025771535239549084\ \(0\)\
\-\ with\\:\\ 0\\.02557796776865826\ \(0\)\
\-\ 10\\:\\ 0\\.025460915134097536\ \(0\)\
\-\ axial\\:\\ 0\\.02515119286564878\ \(0\)\
\-\ due\\:\\ 0\\.025028526435998885\ \(0\)\
\-\ who\\:\\ 0\\.024629815868560542\ \(0\)\
\-\ patients\\:\\ 0\\.024494530213714005\ \(0\)\
\-\ prior\\:\\ 0\\.024361600624775562\ \(0\)\
\-\ both\\:\\ 0\\.024280933738236133\ \(0\)\
\-\ more\\:\\ 0\\.02390899444700328\ \(0\)\
\-\ abdominal\\:\\ 0\\.023814055000465108\ \(0\)\
\-\ none\\:\\ 0\\.02379520799558758\ \(0\)\
\-\ consistent\\:\\ 0\\.023609254022208283\ \(0\)\
\-\ noted\\:\\ 0\\.023085691551144153\ \(0\)\
\-\ small\\:\\ 0\\.02246022271750843\ \(0\)\
\-\ it\\:\\ 0\\.022288335486826967\ \(0\)\
\-\ may\\:\\ 0\\.02191150511535193\ \(0\)\
\-\ but\\:\\ 0\\.021531388294691877\ \(0\)\
\-\ contrast\\:\\ 0\\.02115597350383088\ \(0\)\
\-\ images\\:\\ 0\\.020140887967050006\ \(0\)\
\-\ within\\:\\ 0\\.020053917412448073\ \(0\)\
\-\ male\\:\\ 0\\.01938639443972713\ \(0\)\
\-\ that\\:\\ 0\\.01889542069280077\ \(0\)\
\-\ from\\:\\ 0\\.017292876788832484\ \(0\)\
\-\ not\\:\\ 0\\.017189187179433758\ \(0\)\
\-\ history\\:\\ 0\\.016635411124630663\ \(0\)\
\-\ are\\:\\ 0\\.01652205621457118\ \(0\)\
\-\ at\\:\\ 0\\.016446212820279305\ \(0\)\
\-\ year\\:\\ 0\\.013418663270134095\ \(0\)\
\-\ on\\:\\ 0\\.013150310002360761\ \(0\)\
\-\ old\\:\\ 0\\.012886561724892321\ \(0\)\
